Strides Pharma surges with arm getting USFDA’s approval for Polyethylene Glycol, Electrolytes

24 Dec 2018 Evaluate

Strides Pharma Science is currently trading at Rs. 463.95, up by 3.95 points or 0.86% from its previous closing of Rs. 460.00 on the BSE.

The scrip opened at Rs. 463.45 and has touched a high and low of Rs. 464.15 and Rs. 456.85 respectively. So far 8617 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 875.72 on 27-Dec-2017 and a 52 week low of Rs. 334.10 on 08-Jun-2018.

Last one week high and low of the scrip stood at Rs. 487.90 and Rs. 456.85 respectively. The current market cap of the company is Rs. 4119.25 crore.

The promoters holding in the company stood at 30.79%, while Institutions and Non-Institutions held 47.54% and 21.68% respectively.

Strides Pharma Science’s step?down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution USP, 236 grams/2.97 grams/6.74 grams/5.86 grams/22.74 grams/4 Liter from the United States Food & Drug Administration (USFDA). The product is a generic version of GoLYTELY of Braintree Laboratories, Inc.

The company has 80 cumulative ANDA filings with USFDA of which 55 ANDAs have been approved including 11 approvals received in FY 19.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×